Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
1990-1999
Title
Created Date
Dose-dependent pharmacokinetics of all-trans-retinoic acid
19 January 2021
Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
17 December 2020
Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo
05 November 2020
Effects of vitamin D and retinoids on the differentiation and growth in vitro of canine osteosarcoma and its clonal cell lines
28 October 2020
Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro
22 October 2020
Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells
20 October 2020
Somatostatin and the treatment of cancer
10 October 2020
Point mutation of the somatostatin receptor 2 gene in the human small cell lung cancer cell line COR-L103
01 October 2020
1,25-Dihydroxyvitamin D3 inhibits tenascin-C expression in mammary epithelial cells
24 September 2020
Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats
11 September 2020
Display #
5
10
15
20
25
30
50
100
All
Page 6 of 60
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
Search
Follow us...
Latest
Molecular and cellular mechanisms of melatonin in breast cancer
Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
Melatonin as an adjuvant treatment modality with doxorubicin
Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells
Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines
Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in the rat liver
Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis
Melatonin protects rat liver against irradiation-induced oxidative injury
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression
Melatonin inhibits FAK signaling to suppress PD-L1 expression and enhance chemosensitivity in triple-negative breast cancer
Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence
Radiomitigation by Melatonin in C57BL/6 Mice: Possible Implications as Adjuvant in Radiotherapy and Chemotherapy
Targeting growth hormone in cancer: future perspectives
Tumour-Derived Human Growth Hormone As a Therapeutic Target in Oncology
Melatonin induces apoptosis and cell cycle arrest in cervical cancer cells via inhibition of NF-κB pathway
Molecular basis of melatonin protective effects in metastasis: A novel target of melatonin
GH and IGF1 in cancer therapy resistance
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
Bibliography
How effective is chemo therapy?
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Complete objective response to biological therapy of plurifocal breast carcinoma
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Vademecum
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer